Inspire Medical Systems, Inc. (NYSE:INSP) CTO John Rondoni Sells 583 Shares

Inspire Medical Systems, Inc. (NYSE:INSP) CTO John Rondoni sold 583 shares of the stock in a transaction on Tuesday, February 11th. The stock was sold at an average price of $170.49, for a total value of $99,395.67. Following the completion of the transaction, the chief technology officer now owns 10,424 shares in the company, valued at approximately $1,777,187.76. This represents a 5.30 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link.

John Rondoni also recently made the following trade(s):

• On Tuesday, January 7th, John Rondoni sold 58 shares of Inspire Medical Systems stock. The stock was sold at an average price of $215.00, for a total transaction of $12,470.00.

Inspire Medical Systems Stock Up 0.1 %

INSP stock opened at $187.23 on Friday. Inspire Medical Systems, Inc. has a 12-month low of $123.00 and a 12-month high of $257.40. The firm has a market cap of $5.61 billion, a PE ratio of 174.98 and a beta of 1.32. The business has a 50 day moving average of $189.20 and a 200-day moving average of $191.36.

Inspire Medical Systems (NYSE:INSP) last issued its quarterly earnings results on Monday, February 10th. The company reported $1.15 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.74 by $0.41. Inspire Medical Systems had a net margin of 4.37% and a return on equity of 5.30%. On average, research analysts expect that Inspire Medical Systems, Inc. will post 1.33 earnings per share for the current year.

Institutional Investors Weigh In On Inspire Medical Systems

Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Creative Planning grew its stake in Inspire Medical Systems by 12.4% in the 2nd quarter. Creative Planning now owns 2,575 shares of the company’s stock valued at $345,000 after buying an additional 284 shares in the last quarter. GAMMA Investing LLC increased its stake in Inspire Medical Systems by 559.3% in the 3rd quarter. GAMMA Investing LLC now owns 178 shares of the company’s stock worth $38,000 after acquiring an additional 151 shares during the last quarter. CWM LLC grew its holdings in shares of Inspire Medical Systems by 550.5% during the third quarter. CWM LLC now owns 8,105 shares of the company’s stock worth $1,711,000 after purchasing an additional 6,859 shares in the last quarter. Exchange Traded Concepts LLC bought a new position in shares of Inspire Medical Systems in the third quarter worth approximately $100,000. Finally, nVerses Capital LLC raised its stake in Inspire Medical Systems by 18.8% in the third quarter. nVerses Capital LLC now owns 1,900 shares of the company’s stock valued at $401,000 after purchasing an additional 300 shares in the last quarter. 94.91% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

A number of brokerages have recently issued reports on INSP. Royal Bank of Canada reiterated an “outperform” rating and set a $260.00 price objective on shares of Inspire Medical Systems in a report on Tuesday. Robert W. Baird cut their price target on Inspire Medical Systems from $252.00 to $248.00 and set an “outperform” rating for the company in a research note on Tuesday. Stifel Nicolaus lowered their price objective on Inspire Medical Systems from $200.00 to $190.00 and set a “hold” rating for the company in a research note on Tuesday, January 21st. KeyCorp restated an “overweight” rating and issued a $234.00 target price (down previously from $236.00) on shares of Inspire Medical Systems in a report on Friday, January 24th. Finally, Piper Sandler cut their target price on Inspire Medical Systems from $260.00 to $233.00 and set an “overweight” rating on the stock in a research report on Monday. Three investment analysts have rated the stock with a hold rating and eight have given a buy rating to the company’s stock. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $228.82.

Inspire Medical Systems Company Profile

Inspire Medical Systems, Inc, a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA.